
Last 4 earnings calls · through Q2 FY2026
The bull case rests on a structural cost advantage: cheap North American gas lets CF earn wide margins at world nitrogen prices, whatever those prices turn out to be.
Growth comes from Blue Point, a joint-venture ammonia plant that management says is permitted and on schedule, adding volume into a market short of new supply.
Management raised its own estimate of mid-cycle earnings, arguing that higher global construction costs now justify a higher nitrogen price than the old model assumed.
Falling net debt and steady buybacks mean each remaining share owns more production capacity, which management says the market does not recognize.
The bear case is that earnings reflect a supply shock: today's prices owe more to disrupted Middle East exports and lost production than to anything durable.
CF's own plants are not immune, and the Yazoo City outage has been pushed out once already, removing production and loading fixed costs onto the rest of the network.
New ammonia plants in Texas, Qatar and Nigeria and returning Chinese urea exports will eventually meet demand and pull prices back toward the cost curve.
Blue Point is large, built with partners and exposed to tariffs and labor costs, and its low-carbon premium is not yet proven at scale.
In short: Blue Point is permitted and moving to construction, while the Yazoo City rebuild has slipped into 2027.
Management says all permits are in hand and nearly all long-lead equipment is ordered, so the plant remains on schedule and underpins the growth plan.
Management previously framed $2.5 billion of mid-cycle EBITDA; it now calls $2.9 billion the baseline, arguing higher capital costs have reset the nitrogen price needed to justify new plants.
Management first guided to the fourth quarter of 2026; it now points to the first half of 2027 after electrical equipment lead times extended, keeping a year of production and margin off the books.
Management says the cost gap between a U.S. project and a low-cost gas region has narrowed sharply, and tariffs and labor remain open variables for Blue Point.
Free cash flow of $1.9 billion equals 24.7% of revenue, so the business turns a large share of each sales dollar into cash it can deploy or return.
Two thirds of free cash flow went back to shareholders over the past year through buybacks and dividends, and management says the remaining authorization will be executed.
Blue Point's heaviest construction years are still ahead, so a rising capital budget will compete with repurchases for the same cash.
With the site down, fixed cost absorption and higher-cost purchased ammonia raised costs in the quarter, and management expects insurance to offset rather than eliminate the hit.
In short: Low-cost U.S. gas supports pricing, while nitrogen stays cyclical and low-carbon demand is unproven.
That spread is the core of CF's cost advantage, and management expects it to narrow only modestly as new liquefied natural gas demand draws on global supply.
Management previously framed the EU carbon border mechanism as an issue mainly for European producers whose survival was unclear; it now says the policy is in place and the direction has strengthened.
From fiscal 2022 to fiscal 2024 the operating margin dropped from 48.2% to 29.4%, showing how far profits fall when supply catches up with demand in this cyclical industry.
The annual report warns the market for low-carbon ammonia may be slow to develop or not develop at all, and management's baseline excludes any premium, so that upside is optional.